Top Story

Drinking coffee reduces risk for death, negative health outcomes

November 22, 2017

Consuming coffee lowered the risk for death and a broad spectrum of health outcomes, according to a report recently published in BMJ.

“It is important to systematically assess the totality of higher level evidence of the effects of coffee consumption on all health outcomes,” Robin Poole, MB, ChB, MSc, of the academic unit of primary care and population sciences, University of Southampton, United Kingdom, and colleagues wrote. “This approach can help contextualize the magnitude of the association across health outcomes and importantly assess the existing research for any harm that could be associated with increased consumption.”

In the Journals Plus

Extended red blood cell storage does not increase in-hospital mortality

November 22, 2017
Transfusing red blood cells stored longer than 35 days did not increase risk for in-hospital death compared with fresh blood, according to a secondary analysis of the…

Multinational study to compare three regimens for first-line treatment of advanced renal cell carcinoma

November 22, 2017
A multinational study is underway to compare three treatment strategies for patients with previously untreated advanced or metastatic kidney cancer. The CheckMate 9ER…
In the Journals Plus

Prevalence of secondary cancers underscores need for trial inclusion

November 22, 2017
A quarter of older adults newly diagnosed with cancer from 2009 to 2013 had a prior cancer history, according to an observational study published in JAMA Oncology. …
Meeting News

Telemedicine offers access to state-of-the-art cancer care in rural areas

November 22, 2017
NEW YORK — Every patient with cancer does not live in a major metropolitan area with direct access to specialized care, but there are ways to provide individuals…
More Headlines »

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
More »
Resource Centers


Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Current Issues
View the Current Issue
HemOnc Today